Published in Int J Cancer on March 04, 2011
The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology (2013) 3.89
Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy. Cancer Discov (2016) 2.16
Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog (2012) 1.26
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control (2012) 1.17
Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia (2011) 1.08
The role of Mediterranean diet on the risk of pancreatic cancer. Br J Cancer (2013) 1.07
Role of bacterial infections in pancreatic cancer. Carcinogenesis (2013) 1.06
Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort. Am J Clin Nutr (2013) 1.01
Body mass index and cancer incidence: the FINRISK study. Eur J Epidemiol (2014) 0.98
Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer (2012) 0.95
Epidemiology of pancreatic cancer and the role of family history. J Surg Oncol (2012) 0.94
Obesity and cancer pathogenesis. Ann N Y Acad Sci (2014) 0.93
Diabetes, pancreatic cancer, and metformin therapy. Front Physiol (2014) 0.92
Association of body mass index and risk of death from pancreas cancer in Asians: findings from the Asia Cohort Consortium. Eur J Cancer Prev (2013) 0.91
Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages. PLoS One (2015) 0.91
Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS. Am J Epidemiol (2013) 0.89
Obesity and survival in population-based patients with pancreatic cancer in the San Francisco Bay Area. Cancer Causes Control (2012) 0.88
Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case-control study in Japan. BMC Cancer (2013) 0.86
Diabetes and pancreatic cancer. Minerva Gastroenterol Dietol (2012) 0.85
Dairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Ann Oncol (2014) 0.84
Exocrine pancreatic carcinogenesis and autotaxin expression. PLoS One (2012) 0.81
Effect of Body Mass Index on Overall Survival of Pancreatic Cancer: A Meta-Analysis. Medicine (Baltimore) (2016) 0.81
Obesity and cancer: the role of vitamin D. BMC Cancer (2014) 0.79
Adipocytes WNT5a mediated dedifferentiation: a possible target in pancreatic cancer microenvironment. Oncotarget (2016) 0.78
Surveillance for neoplasia in the pancreas. Best Pract Res Clin Gastroenterol (2016) 0.78
A pooled analysis of body mass index and pancreatic cancer mortality in african americans. Cancer Epidemiol Biomarkers Prev (2014) 0.78
Epidemiology of pancreatic cancer. World J Gastroenterol (2016) 0.78
Investigating Physical Activity in the Etiology of Pancreatic Cancer: The Age at Which This Is Measured Is Important and Is Independent of Body Mass Index. Pancreas (2016) 0.77
Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am (2015) 0.77
Association between alcohol consumption and pancreatic cancer risk: a case-control study. PLoS One (2015) 0.77
Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Pancreas (2016) 0.76
Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017. Clin Gastroenterol Hepatol (2016) 0.76
Body mass index, serum total cholesterol, and risk of gastric high-grade dysplasia: A case-control study among Chinese adults. Medicine (Baltimore) (2016) 0.75
Diet and Pancreatic Cancer Prevention. Cancers (Basel) (2015) 0.75
Gene-by-Environment Interactions in Pancreatic Cancer: Implications for Prevention. Yale J Biol Med (2015) 0.75
Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Ann Oncol (2015) 0.75
Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study. Biol Sex Differ (2016) 0.75
Abdominal Obesity and Lung Cancer Risk: Systematic Review and Meta-Analysis of Prospective Studies. Nutrients (2016) 0.75
Abdominal Obesity and Gastroesophageal Cancer Risk: Systematic Review and Meta-analysis of Prospective Studies. Biosci Rep (2017) 0.75
Statins and pancreatic cancer. Oncol Lett (2017) 0.75
Dietary total antioxidant capacity and pancreatic cancer risk: an Italian case-control study. Br J Cancer (2016) 0.75
Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser (1995) 57.68
A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev (2007) 14.60
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 10.99
Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57
Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr (2002) 7.01
Creation of a clinical classification. International statistical classification of diseases and related health problems--10th revision, Australian modification (ICD-10-AM). Health Inf Manag (1997) 6.36
Comparison of self-reported and measured height and weight. Am J Epidemiol (1982) 4.92
Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA (2001) 4.30
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA (2009) 3.86
The Melbourne Collaborative Cohort Study. IARC Sci Publ (2002) 3.45
Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41
Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol (2002) 2.83
Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine (2006) 2.61
Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev (2005) 2.16
Lack of association of physical activity and obesity with incident pancreatic cancer in elderly women. Cancer Epidemiol Biomarkers Prev (2005) 1.92
Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol (2008) 1.60
Diet and alcohol consumption and lung cancer risk in the New York State Cohort (United States) Cancer Causes Control (1997) 1.51
The underlying basis for obesity: relationship to cancer. J Nutr (2002) 1.42
Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol (2008) 1.35
Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev (2006) 1.32
Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev (2001) 1.28
Insulin resistance and obesity. The role of fat distribution pattern. Diabetes Care (1996) 1.25
Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women. Int J Cancer (2009) 1.23
Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J Natl Cancer Inst (2006) 1.21
Nutritional factors and pancreatic cancer: a case-control study from south-west Poland. Int J Cancer (1991) 1.21
Physical activity, anthropometric factors and risk of pancreatic cancer: results from the Canadian enhanced cancer surveillance system. Int J Cancer (2001) 1.21
The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev (2006) 1.20
Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol (1993) 1.19
Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev (2009) 1.19
Anthropometric factors and pancreatic cancer in a population-based case-control study in the San Francisco Bay area. Cancer Causes Control (2005) 1.17
Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer (1996) 1.15
Physical activity, body weight, and pancreatic cancer mortality. Br J Cancer (2003) 1.13
Glycemic index, glycemic load, and pancreatic cancer risk (Canada). Cancer Causes Control (2005) 1.10
Glycemic load, glycemic index, and carbohydrate intake in relation to pancreatic cancer risk in a large US cohort. Cancer Causes Control (2007) 1.07
The association of body mass index and pancreatic cancer in residents of southeastern Michigan, 1996-1999. Am J Epidemiol (2005) 1.06
A prospective study of physical activity and the risk of pancreatic cancer among women (United States). BMC Cancer (2008) 1.01
Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control (2007) 0.96
Obesity and pancreatic cancer: overall evidence and latency period. Cancer Epidemiol Biomarkers Prev (2005) 0.90
Anthropometry and pancreatic cancer risk: an illustration of the importance of microscopic verification. Cancer Epidemiol Biomarkers Prev (2007) 0.84
Risk of pancreatic carcinoma in smokers enhanced by weight gain. Results from 10-year follow-up of the Malmö preventive Project Cohort Study. Int J Pancreatol (1996) 0.77
Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol (2002) 35.63
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA (2002) 28.72
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18
A common allele on chromosome 9 associated with coronary heart disease. Science (2007) 20.37
Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med (2008) 18.34
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol (2005) 17.45
Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet (2008) 15.43
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation (2003) 12.78
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol (2003) 12.24
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst (2012) 11.91
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr (2006) 10.95
Association between mortality and indicators of traffic-related air pollution in the Netherlands: a cohort study. Lancet (2002) 9.69
Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ (2013) 9.38
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med (2007) 9.04
Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst (2004) 8.77
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Spatial analysis of air pollution and mortality in Los Angeles. Epidemiology (2005) 8.64
Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet (2009) 8.42
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med (2012) 7.47
Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics (2006) 7.40
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA (2010) 7.12
Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99
Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96
Aspirin use and survival after diagnosis of colorectal cancer. JAMA (2009) 6.93
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA (2011) 6.45
Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect (2004) 6.43
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut (2008) 6.26
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet (2008) 6.26
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature (2008) 6.24
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med (2002) 6.19
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04
Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn (2005) 6.00
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95
Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality. Res Rep Health Eff Inst (2009) 5.92
Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst (2008) 5.82
Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol (2010) 5.79
Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79
A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med (2004) 5.68
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer (2007) 5.57
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes (2003) 5.43
Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med (2008) 5.43
Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol (2009) 5.37
Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst (2005) 5.32
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol (2004) 5.29
The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust. J Natl Cancer Inst (2012) 5.27
Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation (2009) 5.26
Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med (2006) 5.24
Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol (2006) 5.22
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14